Lasa Supergenerics Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting

Lasa Supergenerics' board approved the financial results for the quarter ended March 31, 2026. Auditors issued a qualified opinion, highlighting unquantified losses from an uninsured factory fire and unassessed impairment of Rs 16.67 Cr intangible assets. The company reported a net loss of Rs (4.16) Cr.